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Amyotrophiclateralsclerosis(ALS)patientswithpredominantuppermotorneuron(UMN)signsoccasionallyhavehyperintensity
of corticospinal tract (CST) on T2- and proton-density-(PD-) weighted brain images. Diﬀusion tensor imaging (DTI) was used
to assess whether diﬀusion parameters along intracranial CST diﬀer in presence or absence of hyperintensity and correspond to
UMN dysfunction. DTI brain scans were acquired in 47 UMN-predominant ALS patients with (n = 21) or without (n = 26) CST
hyperintensity and in 10 control subjects. Fractional anisotropy (FA), mean diﬀusivity (MD), axial diﬀusivity (AD), and radial
diﬀusivity (RD) were measured in four regions of interests (ROIs) along CST. Abnormalities (P<0.05) were observed in FA, AD,
or RD in CST primarily at internal capsule (IC) level in ALS patients, especially those with CST hyperintensity. Clinical measures
corresponded well with DTI changes at IC level. The IC abnormalities suggest a prominent axonopathy in UMN-predominant
ALS and that tissue changes underlying CST hyperintensity have speciﬁc DTI changes, suggestive of unique axonal pathology.
1.Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive degener-
ation of motor neurons in the brain and spinal cord whose
cause is unknown [1]. It is also unclear whether the motor
neurondegenerationbeginsintheperikaryon(cellbody)asa
neuronopathy and proceeds anterogradely, or along the axon
as an axonopathy and proceeds retrogradely. Brain motor
neurons, mostly in the primary motor cortex (upper motor
neurons),projecttheiraxonscaudallyalongthecorticospinal
tract (CST) through the brainstem to the spinal cord where
theysynapseontoanteriorhorncells(lowermotorneurons).
Progressive degeneration of these two motor neuron pools
results in ALS with upper motor neuron (UMN) signs
(hypertonicity, hyperreﬂexia, and pathologic reﬂexes) and
lower motor neuron (LMN) signs (muscle fasciculations,
atrophy, and weakness) both being required for diagnosis
[1]. A certain percentage of ALS patients present with UMN-
predominant disease, and few or no clinically detectable
LMN signs. By El Escorial criteria, they are usually initially
categorized as possible or, at most, probable with laboratory
support ALS because of the limited extent of LMN ﬁndings
[2]. As disease progresses, their LMN dysfunction may
remain either limited in degree or become more extensive.
Independent of this observation, a relatively small per-
centage of ALS patients display bilateral hyperintensity of
the corticospinal tract (CST) on T2- and proton-density-
(PD-) weighted MRI sequences [1]. Such hyperintensity
can be seen anywhere along the rostrocaudal extent of
the intracranial CST extent from just beneath the primary
motor cortex, corona radiata, and centrum semiovale, but
it tends to be most prominent in the posterior limb of the
internal capsule and cerebral peduncles. A single study in
1994 of three ALS patients with CST hyperintensity who at
postmortem had demyelination and Wallerian degeneration
in the posterior limb of the internal capsule (IC) [3].2 Journal of Aging Research
Unexpectedly, we have identiﬁed other ALS patients with
similar UMN-predominant clinical presentations but with-
out CST hyperintensity. The reason for this variability
between presence or absence of CST hyperintensity and
the essentially identical UMN-predominant clinical features
is unclear but may reﬂect a diﬀerent location of maxi-
mal pathology in the nonhyperintense group CST (e.g.,
in spinal cord), or intracranial pathologies with distinct
axonal/periaxonal characteristics.
Previous brain MRI reports of hyperintensity of CST
in ALS have been qualitative using conventional T2- and
PD-weighted [1]a sw e l la sF L A I R - w e i g h t e d[ 1]s e q u e n c e s .
Because such qualitative approaches depend on several
factors, including quality of MR image, limits of visual
detectability, and the interpreter’s experience, more quan-
titative MR methods would validate these ﬁndings and
potentially provide insights into pathogenesis of the CST
hyperintensity. Diﬀusion tensor imaging (DTI) is a relatively
recently described modality based on the freedom with
which water molecules (protons) move randomly within
tissue, with intact myelinated axons providing the greatest
restriction to movement between them (high anisotropy)
[4]. Because DTI signal is dependent on microscopic-level
events, it has the potential of detecting tissue pathology
at/near submacroscopic levels, even before the changes are
visible by conventional MRI. Identifying pathologic changes
noninvasively at early stages would shorten time to diagnosis
and allow timely therapeutic intervention. Because the CST
and other subcortical white matter in ALS brain are usually
normal in appearance by conventional MRI, DTI should still
be able to detect abnormalities. Furthermore, the organi-
zation of subcortical myelinated motor axons as compact
parallel bundles (e.g., CST) can be ideally interrogated by
DTI because its metrics will reﬂect whether they are intact
(healthy) or disrupted (degenerating).
Therefore, the main goal of this study was to use DTI
obtained at 1.5T as part of routine clinical neuroimaging of
ALS patients with predominant UMN signs for quantitative
evaluation of the intracranial CST, which in one group
was hyperintense on T2- and PD-weighted sequences. This
would allow us to determine where abnormalities in DTI
metrics occur along the CST in our UMN-predominant ALS
patients, and whether quantitative diﬀerences are detectable
corresponding to the qualitative presence or absence of
CST hyperintensity. We hypothesized that motor neuron
degeneration in UMN-predominant ALS is anterograde,
arising primarily in the perikaryon as a neuronopathy. If
this is the case, DTI metrics would be expected to be more
abnormal at more rostral levels of the CST intracranially.
Second, we hypothesized that CST hyperintensity in ALS
brain reﬂects a more extreme case of such anterograde
degeneration thathasuniquetissuecharacteristicsdetectable
by DTI.
By testing these hypotheses, we hope to have a better
understanding of CST degeneration in UMN-predominant
ALS patients and to identify quantitative DTI measures
which may be useful in objectively diﬀerentiating disease
subtypes.
2. Methods
2.1.Demographics. 1.5TMRIdataobtainedaspartofclinical
neuroimaging evaluation was approved by the Institutional
Review Board at the Cleveland Clinic to be stored and
analyzed as deidentiﬁed images after patients had provided
verbal consent. DTI data were analyzed in the following
patient groups: (1) 10 neurological controls (7 men, 3
women) aged 51.1 ± 7.3 years (mean ± SD, range 28–
80 years), (2) 21UMN-predominant ALS patients (14 men,
7 women) with CST hyperintensity on T2/PD-weighted
images (CST+) aged 52.3 ± 11.02 years (range 32–75 years),
and (3) 26 UMN-predominant ALS patients (14 men, 12
women) without CST hyperintensity identiﬁed on T2/PD-
weighted images (CST−)a g e d5 9 . 5± 12.1 years (range 32–
76 years). UMN-predominant ALS patients were deﬁned as
those with either no lower motor neuron signs or, if present,
then restricted to only one neuraxial level (bulbar, cervical,
or lumbosacral) at the time of MRI. Duration of symptoms
prior to MRI in the CST+ group was 9.6 ± 5.5 months
(mean ± SD) and in the CST− group was 36.4 ± 44.2
months; the large standard deviation is due to two outlier
values in the latter group of 148 and 180 months. El Escorial
diagnostic criteria [2] assigned to each patient after their
clinical evaluation were converted to a numeric form as fol-
lows: possible = 1, probable with lab support = 2, probable =
3, and deﬁnite = 4. This El Escorial criteria score in the CST+
group was 1.81 ± 0.98 (mean ± SD) and in the CST− group
was 1.37 ± 0.82.
2.2. DTI Data Acquisition. D T Id a t aw e r eo b t a i n e do n
a 1.5T system (Siemens Symphony, Erlangen, Germany)
using echo planar imaging (EPI) sequence along 12
diﬀusion-weighted (b = 1000s/mm2) directions and
one b0 = 0s/mm 2. Imaging parameters were 30 slices,
4mm thick, with 1.9 × 1.9mm in-plane resolution;
pulse sequence parameters were TR = 6000ms, TE =
121ms, EPI factor = 128, number of averages = 6, and
scan time = 7.54 minutes. Gradient-echo ﬁeld map images
were acquired to correct for geometrical distortion caused
by susceptibility artifacts. Field map imaging parameters
were 30 slices, 4mm thick, 4mm slice gap, TR = 500msec,
TEs = 6.11, and 10.87msec. T2-and PD-weighted images
were obtained using dual-echo FSE sequence whose
imaging parameters were number of slices = 40, contiguous,
slice thickness = 4mm, and in-plane resolution = 0.9 ×
0.9mm; pulse sequence parameters were repetition time
(TR) = 3900ms, TE = 26ms and 104ms, echo train
length or turbo factor = 7, and number of averages = 1;
total scan time = 3.5 minutes.
2.3. Data Processing. D T Ii m a g e sw e r eﬁ r s tc o r r e c t e df o r
susceptibility artifacts and eddy current distortions using
FSL FUGUE and eddy current distortion correction algo-
rithm in FSL (http://www.fmrib.ox.ac.uk/fsl/)[ 5–7]. The
b-matrix was rotated in order to preserve the correct
orientation information after eddy current and oblique
angle corrections [8, 9]. The above preprocessed DTIJournal of Aging Research 3
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Figure 1: Corticospinal tract (CST) reconstructed using tractography superimposed on a subject’s own FA color map in (a) sagittal, (b)
axial, and (c) coronal planes.
images were then processed using DTI Studio open software
(https://www.mristudio.org/)[ 10]. DTI matrix for each
voxel element was calculated based on multivariate linear
least square ﬁt. The tensor matrix was then diagonalized
to derive principal eigenvalues and eigen vectors. Maps of
diﬀusion metrics, namely, fractional anisotropy (FA), mean
diﬀusivity (MD mm2s−1), axial diﬀusivity (AD, λ|| mm2s−1),
and radial diﬀusivity (RD, λ⊥ mm2s−1), were obtained.
Virtual nerve ﬁbers were reconstructed using the ﬁber
assignment by continuous tracking (FACT) algorithm [10],
described in detail elsewhere [11]. Fiber tracking parameters
were initiated from every voxel with FA = 0[ 12], threshold
for termination 0.2 [12], and a bending angle of 41◦.
After above steps, both control and ALS patients’ CST
ﬁber tracts on both left and right sides were reconstructed
(“tractography”) following Wakana et al.’s method [12]b y
placing ﬁrst ROI caudally in cerebral peduncle and the
second rostrally just below the primary motor cortex. Four
regions of interest (ROIs) were identiﬁed ap r i o r iat speciﬁc
levels along the CST (using b0 = 0 and FA images) for DTI
measures, including cerebral peduncle (CP), posterior limb
of the internal capsule (IC), and centrum semiovale at top
of lateral ventricle (LV) and subjacent to primary motor
cortex (MC). DTI metrics of FA, MD, AD, and RD were
measured in each ROI after superimposing each subject’s
own CST tractography mask on their DTI maps. Values were
then compared between ALS patients and controls and also
betweenthepatientgroups.Figure 1showstheleftCSTmask
superimposed on a subject’s FA color map.
StatisticalcomparisonsforeachoftheDTImetricsacross
control and patient groups were carried out using SPSS
16.0 (SPSS Inc., Chicago, Ill, USA). Based on data meeting
the assumptions of ANOVA, one of the following statistical
methods was used with a signiﬁcance level of P<0.05.
One-way ANOVA followed by Tukey’s post hoc test was
carried out when the assumptions of both normality and
equal variance were met. If the equal variance assumption
was violated, the Welch ANOVA followed by the Dunnett
T3 post hoc test was employed. When both normality
and equal variance assumptions were violated, the Kruskal-
Wallis nonparametric approach followed by the Bonferroni
correction of the Mann-Whitney test was used. Clinical
parameter of symptom duration prior to MRI was correlated
with DTI metrics in all the 4 ROIs along the CST using
Spearman’s correlation method after correcting for multiple
comparisons using false discovery rate (FDR).
Because abnormalities of DTI values along the CST may
represent degeneration or related pathology, we assessed
whether such metrics correlated with pathologic UMN
signs (spasticity, hyperreﬂexia, and pathologic reﬂexes), as
identiﬁed by neurologic examination performed at clinical
evaluationnear/attimeofMRI.BecauseCSTﬁbersdecussate
below the lowest ROI analyzed for DTI metrics (at the cervi-
comedullary junction), the intracranial CST corresponds to
the contralateral side of body reﬂecting UMN signs. In order
to detect a side-to-side asymmetry in CST DTI values which
may correspond to asymmetry of UMN signs, ratios of side-
to-side DTI values (right to left) for FA, MD, AD, and RD4 Journal of Aging Research
Table 1: Percent correspondence of abnormal CST DTI metrics with appropriate side of body showing more UMN signs.
CP IC LV PMC
Body predominance
of UMN signs Left (%) Right (%) Left (%) Right (%) Left (%) Right (%) Left (%) Right (%)
FA 50 33.00 85 28 68.40 66.60 16.60 45.50
AD (mm2s−1) 50 61.1 30 33 73.6 55.5 41.6 36.3
RD (mm2s−1) 50 55.5 30 94.4 52.6 55.5 58.3 45.4
MD (mm2s−1) 50 55.5 15 94.4 52.6 61.1 58.3 36.3
Key: AD: axial diﬀusivity, CP: cerebral peduncle, CST: corticospinal tract, FA: fractional anisotropy, IC: posterior limb of internal capsule, LV: centrum
semiovale at top of lateral ventricle, MD: mean diﬀusivity, PMC: subjacent to primary motor cortex, RD: radial diﬀusivity, UMN: upper motor neuron.
in all the 4 ROIs along CST were calculated in control and
in both the ALS patient groups. For this analysis, all ALS
patients (both CST+ and CST− groups) were categorized by
their UMN-predominant body signs being primarily right
sided or left sided, based on their clinical evaluation at time
of MRI. Patients with predominantly right body UMN signs
should have more abnormal left CST DTI metrics, and vice
versa. For example, a patient with mostly right body UMN
signs would have lower FA and AD values in the left CST, so
righttoleftratiowouldbegreaterthanorequalto1,whereas
a patient with mostly left body UMN signs would have lower
FAandADvaluesintherightCST,sorighttoleftratiowould
be less than or equal 1. Because an inherent asymmetry was
observed between right and left CST DTI values even in
controls, the mean right to left ratio from control values was
used as a threshold to estimate the number of ALS patients
above (with more right body UMN signs) or below (with
more left body UMN signs) it. A percentage value was then
calculatedofpatientswhoseratioswereabnormalDTIvalues
in CST relative to control, which represents the degree of
correspondence between abnormal DTI values in CST and
the appropriate side of body with pathologic UMN signs, as
shown in Table 1.
3. Results
Mean FA, MD, AD, and RD values for each ROI along the
CST and their signiﬁcant diﬀerences (based on parametric
and nonparametric tests depending on data meeting the
assumptions of the test as described in Methods) between
the 3 groups are given in Figures 2–5. FA showed signiﬁcant
diﬀerence between control and the ALS groups at right IC
and left MC. However, no signiﬁcant diﬀerences in FA values
were observed between ALS subgroups in any of the 4 ROIs
(Figure 2). MD values showed no signiﬁcant diﬀerences in
any of the 4 ROIs among the 3 groups (Figure 3). Axial
and radial diﬀusivities showed signiﬁcant diﬀerences only
between control and ALS CST hyperintense groups and only
at the level of IC (Figures 4 and 5).
The CST was found to be truncated above the LV level,
most prominently on the right compared to left in 12
subjects (of 21, 57%) in the hyperintense CST group; of
these, CST was truncated on the right in 8 (of 12) and
bilaterally in 4. Similarly, CST truncation was observed in
6 subjects in the nonhyperintense CST group (of 26, 23%);
of these, truncation was on the right in all. Truncation of
CST was not observed in any of the 10 control subjects.
Figures 6(a) and 6(b) show CST tractography extending
to the cortex in a typical control subject and a truncated
CST in an ALS subject. Because the same DTI processing
methodology was employed across all subject groups, this
could not have accounted for the observed diﬀerences in
CST truncation. We also investigated whether the absence
of CST above the LV level in some patients may have lead
to not detecting signiﬁcantly diﬀerent DTI metrics in the
MC. Since tractography was used to identify the ﬁbers to
be measured, missing values at the MC level in patients
with truncated CST could underestimate diﬀerences in DTI
metricsbetweengroups.Tocorrectforthispossibility,Mori’s
CST atlas was superimposed on the FA map, and values were
measured in all 4 ROIs along the CST. This did not change
the results, and still no signiﬁcant diﬀerences were observed
in FA values at the MC level of control and ALS groups
even when identifying the CST using Mori’s atlas. We further
investigated whether the quality of DTI scans obtained
at 1.5T, that is, resolution, anisotropic voxel dimension,
and signal/noise ratio, contributed to the CST truncation
problem. 3T DTI data were collected on another set of ALS
patients with (in 1 patient) and without (5 patients) CST
hyperintensity and in control subjects (5 patients). Imaging
parameters of 3T data were almost identical to those of our
1.5T data except that at 3T voxels they were isotropic (2 ×
2 × 2.5mm) resulting in improved resolution, and signal
to noise ratio was higher. CST tractography and analysis on
3T data were performed in an identical manner to the 1.5T
data. Although the number of studies at 3T was limited, we
foundsimilarCSTtruncationin2of5ALSCSThyperintense
patients and none in controls.
SymptomdurationpriortoMRIwassigniﬁcantlyshorter
(P<0.0003) in ALS patients with CST hyperintensity
(median = 13 months) than in those without CST hyperin-
tensity (median = 31 months). No signiﬁcant diﬀerence was
found in El Escorial criteria scores between either of these
two groups. No signiﬁcant correlation was obtained between
symptom duration prior to MRI and DTI metrics on any of
the 4 ROIs along CST.Journal of Aging Research 5
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Figure 2: Fractional anisotropy (FA) at four CST levels on left (a) and right (b), revealing signiﬁcantly lower values in right MC and left IC
of CST hyperintense and CST nonhyperintense patients compared to controls.
∗P < 0.05. Key: CP, cerebral peduncle; IC, posterior limb of
internal capsule, LV, centrum semiovale at top of lateral ventricle, MC, subcortical to motor cortex.
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Figure 3: Mean diﬀusivity (MA) at four CST levels on left (a) and right (b), revealing no signiﬁcant diﬀerences between groups. Key: CP,
cerebral peduncle; IC, posterior limb of internal capsule, LV, centrum semiovale at top of lateral ventricle, MC, subcortical to motor cortex.6 Journal of Aging Research
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Figure 4: Axial diﬀusivity (AD) at four CST levels on left (a) and right (b), revealing signiﬁcantly lower values at the IC level bilaterally
in only CST hyperintense patients compared to controls.
∗P < 0.05. Key: CP, cerebral peduncle; IC, posterior limb of internal capsule, LV,
centrum semiovale at top of lateral ventricle, MC, subcortical to motor cortex.
4. Discussion
Fractionalanisotropy(FA)abnormalitiesseeninthisstudyof
CST at the level of internal capsule agree well with previous
ALS studies [8, 13–17], although reaching signiﬁcance only
on the right. We also found signiﬁcantly lower FA values
in ALS patients at the subcortical motor cortex level on the
left. The reason for this side-to-side variability is unclear. In
general, FA values were reduced in both CST hyperintense
(CST+) and CST nonhyperintense (CST−)A L Sg r o u p s
when compared to controls, but they were not signiﬁcantly
diﬀerent between the ALS groups. The CST+ group did,
however, have lower FA values than the CST− group. Of
note, axial diﬀusivity (AD) and radial diﬀusivity (RD) values
were signiﬁcantly diﬀerent at the IC level only between
controls and the CST+ group and not the CST− group.
Such diﬀerences in AD and RD abnormalities may reﬂect
microanatomical pathologic diﬀerences in the CST in these
two groups of ALS patients. It is known that FA may not
be as reliable a measure as individual AD and RD, from
which FA is calculated. Beaulieu [18] showed that FA value
changes result from either decreased AD, increased RD,
or changes in both. He also demonstrated in animal and
human studies that AD is reﬂective of axonal integrity and
RD is reﬂective of myelin integrity, with abnormalities in
these DTI metrics representing their degeneration [18]. Such
interpretations should, however, be interpreted with caution
in the present study, as they are likely oversimpliﬁcations,
and further studies would be required for conﬁrmation.
Nonetheless, the aforementioned suggests that AD and RD
are more representative of microanatomical integrity than is
F A.I ngeneral,F A,AD ,andRDvaluesw er ediﬀerentbetween
CST+ and CST− ALS groups but failed to reach statistical
signiﬁcance.
Lack of signiﬁcant diﬀe r e n c e si nM Dv a l u e si na l l
ROIs along the CST in this study generally agrees with
other ALS studies [19, 20], although some DTI studies in
ALS have found MD abnormalities at the IC level [21–
23]. Reasons for this discrepancy may include pooling ALS
patients of multiple clinical phenotypes into a single group
inotherstudies,variableDTIdataacquisitionandprocessing
parameters (our processing included oblique angle and
susceptibility artifact corrections, not used in previous DTI
studies in ALS), and use of ROI-based approach (our study
used tractography of patient’s own CST which is more
accurate and reproducible). Furthermore, since ALS results
in not only axonal/myelin degeneration (which would result
in decreased FA and increased MD) but also gliosis [14,
24], the net diﬀusion revealed by MD may not be higher
than control values. If this is the case, MD values would
be expected to be higher in patients with shorter disease
duration (and presumably less time for gliosis) than longer
disease duration.
The fact that we found FA, AD, and RD abnormalities
in the CST primarily at the IC level and not caudally atJournal of Aging Research 7
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Figure 5: Radial diﬀusivity (RD) at four CST levels on left (a) and right (b), revealing signiﬁcantly higher values at the IC level on the right
in only CST hyperintense patients compared to controls.
∗P < 0.05. Key: CP, cerebral peduncle; IC, posterior limb of internal capsule, LV,
centrum semiovale at top of lateral ventricle, MC, subcortical to motor cortex.
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Figure 6: Sagittal views of FA color maps showing tractography-derived CST extending up to the submotor cortex (SMC) level in a control
subject (a) but truncated in an UMN-predominant ALS patient with CST hyperintensity (b).
the CP level, and some abnormalities rostrally, suggests a
degenerative process that may begin at midpoint along the
subcortical myelinated motor axon. Although interpreting
such DTI metrics as proof of axon/myelin loss is inaccurate,
it indicates that CST microanatomy is suﬃciently abnormal
to result in perturbed water (proton) diﬀusion. Postmortem
histopathologic studies of this region may elucidate the
signiﬁcance of these DTI ﬁndings. Supportive evidence that
these DTI abnormalities at the IC level are related to the CST
neurodegenerative process includes FA values showing 85%
correspondence with left body UMN-predominant clinical
signs and radial diﬀu s i v i t ya sw e l la sM Ds h o w i n g9 4 . 4 %
correspondence with right body UMN-predominant clinical
signs. Only correspondence with a 75% or greater threshold
was chosen, to insure only a 25% correspondence occurred
by chance.
Furthermore, the preponderance of CST virtual ﬁbers
truncated at the subcortical motor cortex (MC) level in the
CST+ over the CST− ALS patients (and never in control
subjects) also suggests disease-speciﬁc changes rather than
artifact in data acquisition or processing. How this CST
virtual ﬁber truncation corresponds to axonal pathology is
unclear and invites further study. Failure to detect signiﬁcant
changes in DTI metrics of the CST at the LV level could be
due to eﬀects of the superior longitudinal fasciculus whose
ﬁbers cross perpendicularly at that level. This region in8 Journal of Aging Research
control subjects also has decreased uniformity of ﬁber tracts
(unpublished observations), consistent with crossing ﬁbers
(as measured by Westin’s linear and planar indices [25]).
Duration of ALS symptoms prior to MRI was shorter
in CST+ than in CST− group, which may reﬂect faster
disease progression, although this is uncertain. In an early
neuroimaging-pathologic study, Yagishtia et al. [3]f o u n d
CST hyperintensity on MRI corresponds to demyelination
and axon degeneration suggesting a diﬀerent pathology from
patients without CST hyperintensity. Other studies reported
that ALS patients with CST hyperintensity had rapid clinical
decline initially [1], shorter disease duration, and faster
disease progression [26]. In a separate study evaluating 112
ALS patients over a 10-year period who had undergone at
leastonebrainMRI,wefoundthosewithCSThyperintensity
(n = 35) had signiﬁcantly more rapid disease progression
and shorter survival than those without CST hyperintensity
(n = 77) [27]. It is therefore possible that ALS patients with
CST hyperintensity have diﬀerent underling pathology from
those without CST hyperintensity, which results in faster
diseaseprogression.Inthecontextofsimilarorslightlyworse
FA and AD/RD abnormalities at the IC level of the CST, this
suggests a more rapidly evolving disease process in the CST+
group.Althoughcorrelationsbetweendurationofsymptoms
and individual DTI metrics at each of the ROIs along the
CST did not reach statistical signiﬁcance after correction for
multiple comparisons (false discovery rate correction), there
was a trend for correlation of FA, AD, and RD abnormality
at IC and LV levels with disease duration when P<0.05 is
uncorrected for multiple comparisons.
Although the DTI changes we observe between these
ALS patient groups are small, they support diﬀerences
visualized by qualitative T2/PD images and suggest they
result from real microanatomic pathologic changes, such
as inﬂammation, demyelination, axon loss, or gliosis [28].
However, detailed studies correlating CST changes detected
by DTI and T2/PD with postmortem histopathology will be
requiredtodeterminewhatcausestheimagingabnormalities
we have found.
To our knowledge this is the ﬁrst study to use DTI to
quantitatively evaluate the CST after its virtual reconstruc-
tion by tractography and classify UMN-predominant ALS
patients into groups based on the presence or absence of CST
hyperintensity.
5. Conclusion
DTI performed at 1.5T as part of routine clinical brain
MR imaging demonstrates abnormalities in FA and related
parameters predominantly at the IC level of the CST in
UMN-predominant ALS patients compared to control sub-
jects. This correlates with the appropriate body side showing
more prominent UMN signs clinically. In addition, patients
with CST hyperintensity have abnormalities of the AD and
RD components of FA, while those without CST hyperin-
tensity do not, suggesting diﬀerences in tract microanatomy.
Furthermore, subcortical truncation of virtual CST ﬁbers
generated by tractography occurs more frequently in ALS
patients who have CST hyperintensity than those who do
not, again suggesting divergent pathology. Predominance
of DTI abnormalities at the IC level and rostrally suggests
an anterograde process arising from a neuronopathy of
motor neurons forming the CST. Identiﬁcation of these
DTI abnormalities in UMN-predominant ALS patients from
routine clinical scans demonstrates feasibility of acquiring
useful quantitative information with a 1.5T magnet system.
Future DTI studies at 3T with larger control subject group
will conﬁrm these ﬁndings.
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